Faron Pharmaceuticals Oy (AIM:FARN)

Faron Pharmaceuticals Oy Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	50	206	214	210	179	142
Market Cap Growth	-74.14%	-3.97%	2.23%	16.93%	26.00%	16.78%
Enterprise Value	61	214	200	216	181	139
Last Close Price	0.43	1.75	2.00	2.47	2.43	2.16
PB Ratio	-3.08	-12.76	-26.57	-15.95	-17.63	58.08
P/TBV Ratio	-	-	-	-	-	83.93
Debt / Equity Ratio	-1.33	-1.33	-1.24	-0.86	-1.16	1.22
Net Debt / Equity Ratio	-0.67	-0.67	-0.27	-0.41	-0.55	-1.13
Net Debt / EBITDA Ratio	-0.62	-0.62	-0.14	-0.22	-0.23	0.16
Net Debt / FCF Ratio	-0.69	-0.69	-0.12	-0.26	-0.27	0.15
Quick Ratio	0.68	0.68	0.96	0.47	0.75	1.15
Current Ratio	0.84	0.84	1.09	0.59	0.93	1.68
Return on Equity (ROE)	-	-	-	-	-	-3961.49%
Return on Assets (ROA)	-85.32%	-85.32%	-102.64%	-166.16%	-140.19%	-122.44%
Return on Capital Employed (ROCE)	1190.80%	1190.80%	-794.60%	596.20%	-3428.10%	-351.60%
Earnings Yield	-47.76%	-11.54%	-9.99%	-12.80%	-14.20%	-12.50%
FCF Yield	-	-7.59%	-8.60%	-9.85%	-11.37%	-13.11%
Buyback Yield / Dilution	-26.21%	-26.21%	-36.07%	-17.79%	-8.88%	-10.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.